THE BRITISH SOCIETY FOR HAEMATOLOGY
The BSH aims to promote the study and practice of Haematology within the UK and more broadly throughout Europe and the rest of the world through its annual scientific meeting, educational and scientific grants, guidelines production, through its website, its journal the British Journal of Haematology. The BSH is open to all Haematology professionals.
Objects
TO ADVANCE THE STUDY OF HAEMATOLOGY AND TO FACILITATE CONTACT BETWEEN PERSONS INTERESTED IN HAEMATOLOGY
Financial health, per its FY2025 accounts
The accounts state that the charity holds substantial unrestricted reserves of £12,061,368, significantly exceeding its stated operational reserve policy target of £2,550,000. The trustees confirm that these resources are adequate to continue operations for the short and medium term, with no material uncertainties identified regarding going concern. The charity reported a net decrease in total funds of £11,492 for the year, driven by investment losses and designated fund expenditures, while maintaining a strong cash and investment position.
What the accounts disclose
“There was 1 employee whose emoluments for the year were between £80,000 - £90,000 (2024:0).” — page 25
“There was 1 employee whose emoluments for the year were between £80,000 - £90,000 (2024:0).” — page 25
“The largest income stream remains the share of the profits of the British Journal of Haematology (both BJHaem & eJHaem) which was £1,040,791 (2024: £1,068,978).” — page 13
“The Society has incurred no financial costs in any fundraising activity. Neither did the Society engage any external fundraisers, nor did it receive any complaints in respect of its fundraising activities.”
“An allowance of 20% for market volatility was agreed, resulting in an Operational Reserve figure of £2,550,000. In addition, there should be a cash reserve of £500,000 at the year end to maintain fluidity” — page 14
“The charity wholly owns its trading subsidiary, BSH Enterprises Limited (BSHE), through which the organisation of the Annual Scientific Meeting (ASM) for the British Society for Haematology is conducted.” — page 15
Year-over-year changes
- Employees paid over £60,000: 0 (FY2024) → 1 (FY2025).
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 30/09/2025
- Volunteers: 583
- Employees paid over £60,000: 1 (£100,001–£110,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 30/09/2024
- Volunteers: 569
- Employees paid over £60,000: 2 (£60,001–£70,000: 2)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 30/09/2023
- Volunteers: 477
- Employees paid over £60,000: 1 (£70,001–£80,000: 1)
- Has a trading subsidiary
Corporate structure
- Registered company of the charity Companies House 02645706
- Trading subsidiary: BSH ENTERPRISES LIMITED Companies House 02677826
- Turnover: £1.8m
- Profit before tax: £676k
- Donated/gift-aided to the charity: £512k
- BSH Enterprises Limited is a wholly owned subsidiary of The British Society for Haematology.
“Gift aid of £512,159 was paid to its parent in relation to the surplus for the year ended 30 September 2024.”
Leadership, per the charity’s website
- Dr John Ashcroft — President
- Carol Bewick — CEO
- Professor Gordon Cook — Vice President
- Huw Rowswell — Treasurer
- Professor Guy Pratt — Secretary
Company officers (Companies House)
- JONES, Gail Lisa, Dr not on trustee list
- GRAINGER, John David, Dr not on trustee list
- MEAD, Adam Joseph, Professor on trustee list
- GOMEZ, Keith, Prof. on trustee list
- DALLEY, Christopher, Dr on trustee list
- MILLER, Laura on trustee list
- HAPUARACHCHI, Tharindi Sangeewanee on trustee list
- KEEFE, David Patrick on trustee list
- SNOWDEN, John Andrew, Professor on trustee list
- MIALL, Fiona Mary, Dr on trustee list
- WARD, Keith David on trustee list
- FIELDING, Kate Ellen on trustee list
- ROWSWELL, Huw on trustee list
- PRATT, Guy, Professor
Property (HM Land Registry)
Structured financials (annual return, FY ending 30/09/2025)
Register events
- Received assets from another charity (12/01/2024)
Trustees
- DR JOHN ASHCROFT
- David Patrick Keefe
- Dr Cathy Burton
- Dr Christopher Dalley
- Dr Fiona Mary Miall
- Dr John Andrew Snowden
- Dr Shankaranarayana Paneesha
- Huw Rowswell
- KEITH WARD
- Kate Ellen Fielding
- Laura Miller
- Prof Gordon Cook
- Professor Adam Mead
- Professor Guy Pratt
- Professor Keith Gomez
- Tharindi Hapuarachchi
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £3.3m | £3.2m |
| 30/09/2024 | £3.3m | £3.1m |
| 30/09/2023 | £2.8m | £2.6m |
| 30/09/2022 | £2.6m | £2.5m |
| 30/09/2021 | £2.8m | £1.9m |
Common questions
Is THE BRITISH SOCIETY FOR HAEMATOLOGY financially healthy?
Per its FY2025 accounts: The accounts state that the charity holds substantial unrestricted reserves of £12,061,368, significantly exceeding its stated operational reserve policy target of £2,550,000. The trustees confirm that these resources are adequate to continue operations for the short and medium term, with no material uncertainties identified regarding going concern. The charity reported a net decrease in total funds of £11,492 for the year, driven by investment losses and designated fund expenditures, while maintaining a strong cash and investment position. Its FY2025 accounts were audited by Haysmacintyre LLP.
What does the highest-paid employee of THE BRITISH SOCIETY FOR HAEMATOLOGY earn?
Per its FY2025 accounts, the highest-paid employee was in the £80,001 - £90,000 band, and 1 employees earned over £60,000.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | 1 | £175k |
Charities like this
- BRITISH SOCIETY FOR HAEMOSTASIS AND THROMBOSIS
- BRITISH SOCIETY FOR RHEUMATOLOGY
- BRITISH SOCIETY FOR CELL BIOLOGY
- THE BRITISH SOCIETY FOR HEART FAILURE
- BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY
- BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE BRITISH SOCIETY FOR HAEMATOLOGY | £3.3m | £80,001 - £90,000 | 1 | above | 0.0% | no doubt |
| BRITISH SOCIETY FOR HAEMOSTASIS AND THROMBOSIS | £12k | — | 0 | unclear | — | no doubt |
| BRITISH SOCIETY FOR RHEUMATOLOGY | £5.4m | — | 0 | above | 0.0% | no doubt |
| BRITISH SOCIETY FOR CELL BIOLOGY | £138k | — | 0 | unclear | — | no doubt |
| THE BRITISH SOCIETY FOR HEART FAILURE | £1.1m | — | 2 | unclear | — | no doubt |
| BRITISH SOCIETY OF BLOOD AND MARROW TRANSPLANTATION AND CELLULAR THERAPY | £638k | — | 0 | unclear | — | no doubt |